PULSE BIOSCIENCES, INC. — Director's Dealing 2025

Sep 23, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PULSE BIOSCIENCES, INC. (PLSE)
CIK: 0001625101
Period of Report: 2025-09-18

Reporting Person: Danahy Kevin Patrick (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-09-18	Common Stock	M	20000	$1.53	Acquired	63298	Direct
2025-09-18	Common Stock	S	20000	$18.49	Disposed	43298	Direct
2025-09-19	Common Stock	M	400	$1.53	Acquired	43698	Direct
2025-09-19	Common Stock	S	400	$18.48	Disposed	43298	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-09-18	Stock Option (right to buy)	$1.53	M	20000	Disposed	2032-09-23	Common Stock (20000)	Direct
2025-09-19	Stock Option (right to buy)	$1.53	M	400	Disposed	2032-09-23	Common Stock (400)	Direct

Footnotes

F1: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025.

F2: The price in column 4 is the weighted average price per share sold. The price per share actually received by the reporting person ranged from $18.48 to $19.48 per share. For all transactions reported in this Form 4 using a weighted average price, the reporting person undertakes upon request by the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range.

F3: Options granted on September 23, 2022, to acquire up to 450,000 shares of Common Stock, in connection with reporting person's promotion, with 25% vesting on each anniversary of grant, pursuant to the terms of an amendment to reporting person's Employment Agreement dated February 9, 2022.